Continued Access Protocol to evaluate the effectiveness of the OCS Liver System to preserve and assess donor livers.
A prospective, single arm, continued access protocol to evaluate the effectiveness of the OCS Liver System to preserve and assess donor livers having one or more of the following characteristics: 1. Donor age equal to or greater than 40 years old, or 2. Expected cross clamp time of 6 hours or greater, or 3. Donor after circulatory death (DCD) with age less than or equal to 55 years; or 4. Steatotic lever \>0% and less than or equal to 40% at time of retrieval, based on pre-retrieval histology) A maximum of 21 sites will enroll up to 184 transplanted liver recipients. The primary effectiveness endpoint will be the incidence of Early Allograft Dysfunction (EAD) or primary non-function. All recipients will be followed for 24 months from the date of transplantation (some of which will be post-market).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
74
OCS Liver System for preserving and assessing donor livers for transplantation
Scripps
La Jolla, California, United States
University of California San Diego
La Jolla, California, United States
Participants With Early Liver Allograft Dysfunction (EAD)
Participants with Early liver Allograft Dysfunction (EAD) or primary non-function, defined as presence of one or more of the following criteria: AST level \> 2000 IU/ml within the first 7 postoperative days; Bilirubin ≥ 10 mg/dl on postoperative day 7; INR ≥ 1.6 on postoperative day 7; or Primary non-functioning graft within the first 7 days (defined as irreversible graft dysfunction requiring emergency liver re-transplantation or death, in the absence of immunologic or surgical causes)
Time frame: 7 days
Patient Survival at Day 30 After Transplant
Patient survival at day 30 post transplantation.
Time frame: 30 days after transplant
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
UCSF
San Francisco, California, United States
Tampa General
Tampa, Florida, United States
Johns Hopkins
Baltimore, Maryland, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Henry Ford Hospital
Detroit, Michigan, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Mount Sinai Hospital
New York, New York, United States
Montefiore Einstein Center for Transplantation
The Bronx, New York, United States
...and 7 more locations